Tumor News and Research

RSS

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.

23 Feb 2023

UTA professor leads a CPRIT-funded study to better craft a personalized cancer immunotherapy

A University of Texas at Arlington bioengineering professor is leading a state-funded project that will try to identify what T-cells are detecting in cancerous cells to better craft a personalized cancer immunotherapy.

23 Feb 2023

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use.

22 Feb 2023

Monitoring the presence of bovine meat and milk factor protein expression may help identify people at risk of colorectal cancer

Bovine meat and milk factors (BMMFs) - initially identified by de Villiers et al. in 2014 - represent a class of infectious agents in beef and cow's milk that have been linked to the development of cancer.

22 Feb 2023

When cancer research turns to the immune system – the critical role of peptides and immunopeptidomics

In this interview, AZoM speaks to Rohan Thakur, the President of Life Science Mass Spectrometry at Bruker, about what the opportunities of the market are and how Bruker is planning on rising to the challenge.

From Bruker Daltonics 22 Feb 2023

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

To create the most effective, personalized treatment plans for patients with Hodgkin lymphoma or other cancers, scientists and clinicians need the clearest picture of the genetic changes leading to the cancer's development.

21 Feb 2023

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Patients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to have more-aggressive tumors and significantly lower overall survival (OS) than those in higher-income neighborhoods, according to research led by Roswell Park Comprehensive Cancer Center.

21 Feb 2023

Ferroptosis could be the key to making effective immunotherapies against liver cancer

Iron-dependent cell death (ferroptosis) is a type of programmed cell death by means of which the body kills off diseased, defective or superfluous cells.

17 Feb 2023

“Cell food” reveals how different metabolic programs regulate T cell persistence

New research from the University of Michigan Rogel Cancer Center reveals that the metabolic pathways that make a specific type of T cell function are different than previously believed.

17 Feb 2023

Scientists discover how a "poisoned" form of protein could spur cancer formation

Scientists at Scripps Research, with collaborators in Japan, have discovered how a "poisoned" form of a protein could set off a cascade of events that encourage the growth of some cancers.

17 Feb 2023

A new trial to assess if butyrate can prevent colon cancer

Researchers discuss a new clinical trial that will determine the efficacy of butyrate administration in preventing colon cancer.

16 Feb 2023

CHLA researchers receive funding to support studies into diffuse intrinsic pontine glioma

Researchers at Children's Hospital Los Angeles have received a nearly $1 million K08 grant from the National Institutes of Health (NIH) - as well as funding from the U.S. Department of Defense - to support studies into diffuse intrinsic pontine glioma (DIPG), a childhood brain tumor with a 0% survival rate.

16 Feb 2023

Small molecule inhibitor reverses malignant hyper-editing by an inflammation-induced protein isoform

Researchers at University of California San Diego School of Medicine, Sanford Stem Cell Institute and Moores Cancer Center report that a late-stage, pre-clinical small molecule inhibitor, called rebecsinib, reverses malignant hyper-editing by an inflammation-induced protein isoform, known as ADAR1 p150.

16 Feb 2023

Tumor News and Research

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

UTA professor leads a CPRIT-funded study to better craft a personalized cancer immunotherapy

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Monitoring the presence of bovine meat and milk factor protein expression may help identify people at risk of colorectal cancer

When cancer research turns to the immune system – the critical role of peptides and immunopeptidomics

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Ferroptosis could be the key to making effective immunotherapies against liver cancer

“Cell food” reveals how different metabolic programs regulate T cell persistence

Scientists discover how a "poisoned" form of protein could spur cancer formation

A new trial to assess if butyrate can prevent colon cancer

CHLA researchers receive funding to support studies into diffuse intrinsic pontine glioma

Small molecule inhibitor reverses malignant hyper-editing by an inflammation-induced protein isoform

Genes encoding T cell receptors vary greatly between persons and populations, study reveals

Smoking and vaping may put healthy young people at risk of severe COVID

Study highlights the interconnectedness of autoimmunity and cancer

Jamaican fruit bat's response to SARS-CoV-2 adapted to human

Protein degradation approach can be used to hit an ‘undruggable’ target against cancer

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Novel predictive index for gastric cancer prognosis

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News